The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?
about
Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer.
P2860
The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prognostic factors of effe ...... fit from ketoconazole therapy?
@en
The prognostic factors of effe ...... fit from ketoconazole therapy?
@nl
type
label
The prognostic factors of effe ...... fit from ketoconazole therapy?
@en
The prognostic factors of effe ...... fit from ketoconazole therapy?
@nl
prefLabel
The prognostic factors of effe ...... fit from ketoconazole therapy?
@en
The prognostic factors of effe ...... fit from ketoconazole therapy?
@nl
P2093
P2860
P356
P1476
The prognostic factors of effe ...... fit from ketoconazole therapy?
@en
P2093
Chun-Guang Ma
Ding-Wei Ye
Guo-Wen Lin
Hai-Liang Zhang
Shi-Lin Zhang
Xu-Dong Yao
Yi-Jun Shen
P2860
P304
P356
10.1038/AJA.2012.57
P577
2012-08-20T00:00:00Z